Fenglin Zhang

1.5k total citations
62 papers, 1.1k citations indexed

About

Fenglin Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fenglin Zhang has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 18 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Fenglin Zhang's work include Cancer, Hypoxia, and Metabolism (12 papers), Adipose Tissue and Metabolism (8 papers) and RNA modifications and cancer (6 papers). Fenglin Zhang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Adipose Tissue and Metabolism (8 papers) and RNA modifications and cancer (6 papers). Fenglin Zhang collaborates with scholars based in China, United States and India. Fenglin Zhang's co-authors include Guomin Shen, Jun‐Wu Zhang, Xiaoling Liu, Xue‐Ru Wu, Qingyan Jiang, Gang Shu, Xing Wang, Xiaotong Zhu, Songbo Wang and Ping Gao and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemistry.

In The Last Decade

Fenglin Zhang

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fenglin Zhang China 21 629 330 158 137 116 62 1.1k
Caroline Goupille France 22 661 1.1× 288 0.9× 213 1.3× 133 1.0× 85 0.7× 55 1.2k
Haejin Yoon South Korea 20 1.0k 1.6× 499 1.5× 201 1.3× 179 1.3× 94 0.8× 29 1.6k
Feng Pan China 23 728 1.2× 323 1.0× 105 0.7× 192 1.4× 137 1.2× 57 1.2k
Lingying Tong United States 12 682 1.1× 423 1.3× 81 0.5× 135 1.0× 87 0.8× 24 1.2k
Xiang Shen China 13 622 1.0× 145 0.4× 175 1.1× 241 1.8× 102 0.9× 33 1.0k
Jisoo Yun South Korea 17 534 0.8× 259 0.8× 100 0.6× 110 0.8× 108 0.9× 41 926
Hsiu‐Chuan Chou Taiwan 25 774 1.2× 185 0.6× 97 0.6× 243 1.8× 90 0.8× 85 1.6k
Hong‐Ye Zhao China 21 878 1.4× 280 0.8× 156 1.0× 143 1.0× 189 1.6× 82 1.5k
Qian Xu China 21 707 1.1× 433 1.3× 57 0.4× 162 1.2× 74 0.6× 82 1.3k
Chang‐Yan Li China 21 905 1.4× 186 0.6× 99 0.6× 127 0.9× 152 1.3× 81 1.5k

Countries citing papers authored by Fenglin Zhang

Since Specialization
Citations

This map shows the geographic impact of Fenglin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglin Zhang more than expected).

Fields of papers citing papers by Fenglin Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenglin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglin Zhang. The network helps show where Fenglin Zhang may publish in the future.

Co-authorship network of co-authors of Fenglin Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Fenglin Zhang. A scholar is included among the top collaborators of Fenglin Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenglin Zhang. Fenglin Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Fenglin, Andrew J. Clair, John F. Dankert, et al.. (2024). Cytokine Receptor-like Factor 1 (CRLF1) and Its Role in Osteochondral Repair. Cells. 13(9). 757–757.
3.
Feng, Liang, et al.. (2024). Recent advances in the reciprocal regulation of m6A modification with non-coding RNAs and its therapeutic application in acute myeloid leukemia. Pharmacology & Therapeutics. 259. 108671–108671. 3 indexed citations
4.
Zhang, Yan, et al.. (2024). P2RX1-blocked neutrophils induce CD8+ T cell dysfunction and affect the immune escape of gastric cancer cells. Cellular Immunology. 408. 104901–104901. 2 indexed citations
5.
Huang, Xiaoyu, Yong Huang, Kexin Liu, et al.. (2024). Intratumoral and Peritumoral Radiomics for Predicting the Prognosis of High-grade Serous Ovarian Cancer Patients Receiving Platinum-Based Chemotherapy. Academic Radiology. 32(2). 877–887. 3 indexed citations
7.
Huang, Xiaoyu, Yong Huang, Fenglin Zhang, et al.. (2024). Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning. npj Precision Oncology. 8(1). 202–202. 3 indexed citations
8.
He, Feng, Fenglin Zhang, Yi Liao, Moon‐shong Tang, & Xue‐Ru Wu. (2022). Structural or functional defects of PTEN in urothelial cells lacking P53 drive basal/squamous-subtype muscle-invasive bladder cancer. Cancer Letters. 550. 215924–215924. 6 indexed citations
9.
Liu, Zihao, Dong He, Wenqing Liu, et al.. (2022). N6-Methyladenosine-modified lncRNA LINREP promotes Glioblastoma progression by recruiting the PTBP1/HuR complex. Cell Death and Differentiation. 30(1). 54–68. 24 indexed citations
10.
Liu, Zihao, Min Han, Zhihai Wang, et al.. (2022). Mechanisms of long non-coding RNAs in biological phenotypes and ferroptosis of glioma. Frontiers in Oncology. 12. 941327–941327. 5 indexed citations
11.
Zhu, Ping, Fenglin Zhang, Xiufeng Bai, et al.. (2018). Human Elongation Factor 4 Regulates Cancer Bioenergetics by Acting as a Mitochondrial Translation Switch. Cancer Research. 78(11). 2813–2824. 16 indexed citations
12.
Zhang, Fenglin, Zhiguang Liu, Yujie Han, Lifang Fan, & Yujing Guo. (2018). A facile electrochemical aptasensing platform based on a polydopamine@graphene composite for protein detection. Analytical Methods. 10(46). 5547–5553. 1 indexed citations
13.
Liu, Zhi, Qing Zhang, Wan Song, et al.. (2018). YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells. Cancer Chemotherapy and Pharmacology. 81(4). 687–695. 20 indexed citations
14.
Xu, Xiaolong, Fenglin Zhang, Xianzhen Chen, & Qi Ying. (2017). MicroRNA-518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB. Molecular Medicine Reports. 16(4). 5326–5332. 16 indexed citations
16.
Zhang, Bo, Jing Wang, Zhen Huang, et al.. (2015). Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer. Oncotarget. 6(42). 44495–44508. 46 indexed citations
17.
Zhao, Yingze, Xiaoling Liu, Guomin Shen, et al.. (2013). Hypoxia induces peroxisome proliferator-activated receptor γ expression via HIF-1-dependent mechanisms in HepG2 cell line. Archives of Biochemistry and Biophysics. 543. 40–47. 28 indexed citations
18.
Pan, Yuan Jiang, Chunlin Wang, Guohan Hu, et al.. (2012). ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1. Journal of Molecular Endocrinology. 49(1). 21–33. 25 indexed citations
19.
Zhang, Fenglin, Guomin Shen, Xiaoling Liu, et al.. (2011). Hypoxic Induction of Human Erythroid-Specific δ-Aminolevulinate Synthase Mediated by Hypoxia-Inducible Factor 1. Biochemistry. 50(7). 1194–1202. 23 indexed citations
20.
Liu, Xiaoling, Fenglin Zhang, Zhiyong Zhou, et al.. (2009). Analysis of two sequence variants in peroxisome proliferator activated receptor gamma gene in Tajik population at high altitudes and Han population at low altitudes in China. Molecular Biology Reports. 37(1). 179–184. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026